The authors previously reported an increase in platelet aggregation in the days after coronary angiography, accompanied at times by worrying cardiovascular disorders (ventricular fibrillation in one case, death in two others). In the present study, ten patients received a platelet antiaggregating drug (ticlopidin) 5 days before their coronary angiography. No significant changes were detected in the test for circulating platelet aggregates (CPA test) in these patients.
Get full access to this article
View all access options for this article.
References
1.
AmmaturoVPerriconeCMininniNZuccarelliBSantoroGPalumboE (1983) Modificazioni emocoagulative (CPA test e AT III) in corso di angiografia coronarica. XXIX Congr. Naz. Soc. Ital. Ematologia, Bologna.
2.
AmmaturoVPerriconeCAcquaGPalumboE (1982) Studio dell'azione antiaggregante piastrinica della ticlopidina mediante il CPA test. Simposio satellite Congr. Naz. Soc. Ital. Medic. Interna – Roma.
3.
PerriconeCAmmaturoVCanazioAPalumboENappiL (1981) II CPA test in vasculopatici periferici diabetici e non. Riunioni Fiorentine de aggiornamento in angiologia – Firenze.
